Product Description
440 MG Trastuzumab For Injection is used in the treatment of breast and stomach cancer. 440 MG Trastuzumab For Injection is given as an injection by a qualified medical professional. It is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer where the food pipe joins your stomach.
Technical Specification
- Application : Clinic, Hospital
- Medicine Type : Allopathic
- Packaging Type : Box
- Strength : 440 mg
- Form : Injection
- Manufacturer : Mylan
- Composition : Trastuzumab for Injection
- Brand : Hertraz
Targeted Therapy for HER2-Positive CancersHertraz 440 mg Injection is specifically formulated for patients diagnosed with HER2-positive breast or metastatic gastric cancers. It employs trastuzumab, a monoclonal antibody, to selectively bind to the HER2 receptor, thereby inhibiting cancer cell proliferation. This targeted approach enhances treatment efficacy while minimizing impact on healthy tissue.
Simple Reconstitution and Administration ProcessPrior to administration, Hertraz must be reconstituted with the provided bacteriostatic water for injection. This ensures proper dissolution and accurate dosing before intravenous infusion. Healthcare professionals will handle the preparation and administration in clinical settings, ensuring patient safety and optimal therapeutic outcomes.
Storage and Shelf-Life InformationTo maintain its efficacy, Hertraz Injection should be stored in a cool and dry environment. The lyophilized powder remains stable for up to 36 months when kept under recommended conditions. Proper storage safeguards the medication until the time of use, which helps guarantee consistent results for patients.
FAQ's of Hertraz 440 mg injection:
Q: How is Hertraz 440 mg Injection prepared and administered?
A: Hertraz 440 mg Injection is first reconstituted with the supplied bacteriostatic water for injection by a healthcare professional. Once properly dissolved, it is given intravenously under close medical supervision in a clinical setting.
Q: What types of cancer is Hertraz 440 mg Injection used to treat?
A: Hertraz is used primarily in the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric cancer, offering a targeted therapy option for these conditions.
Q: When should Hertraz 440 mg Injection be administered to patients?
A: Administration timing and dosage are determined by a doctor based on individual patient needs, disease progression, and treatment guidelines. It is essential to follow the prescribed schedule for optimal benefit.
Q: Where should Hertraz 440 mg Injection be stored before use?
A: The vial should be stored in a cool, dry place as recommended to ensure the stability and potency of the lyophilized powder until it is prepared for use.
Q: What is the process for reconstituting the Hertraz 440 mg Injection?
A: A qualified healthcare professional will add the provided bacteriostatic water for injection to the vial containing the trastuzumab lyophilized powder, gently mixing until fully dissolved before intravenous administration.
Q: What benefits does Hertraz 440 mg Injection offer over traditional chemotherapy?
A: Hertraz delivers monoclonal antibody therapy that specifically targets the HER2 receptor on cancer cells, potentially resulting in higher efficacy and fewer side effects compared to traditional, less specific chemotherapy agents.